Health Care Tempe’s Bio Innovation Hub Kicks Off With First Tenant Opening

Article originally posted on Phoenix Business Journal on March 5, 2020

One of the largest medical technology companies in the world has made the new IDEA Tempe campus its new home, with plans to hire more as the company grows.

BD Peripheral Intervention has leased four of six floors in the building recently completed at the Innovation, Discovery, Education and Arts campus, which encompasses about 18 acres west of the Tempe Center for the Arts on Rio Salado Parkway east of Priest Drive in Tempe.

So far, the medical device manufacturer is the only tenant in that 120,000-square-foot structure. The Boyer Co. is the developer. Okland Construction is general contractor for that project.

If others don’t step forward within the next year or two, Steve Williamson, worldwide president for BD Peripheral, said he’ll snatch the other two floors to make room for future growth.

Williamson said he plans to hire at least 40 people this year for various positions, including roles in regulatory, research and development, clinical trials and marketing. Of the company’s 650 employees across Arizona, 450 will be based at the IDEA campus.

Many positions are technical in nature, which is why Williamson is glad to be near Arizona State University’s Tempe campus.

“ASU graduates 5,000 engineers a year, and 70% stay in the Valley,” Williamson said. “It’s a good crop of people to choose from.”

The company makes minimally invasive medical devices to diagnose and treat cancer, enable kidney dialysis treatment and treat peripheral artery disease.

BD Peripheral Intervention is a $1.8 billion unit owned by Beckton, Dickinson and Co. (NYSE: BDX), a $17 billion operation based in New Jersey.

Beckton, Dickson, also known as BD, purchased BD Peripheral’s parent, C.R. Bard Inc., for $24 billion in 2017.

Find Complete Article Here:

Click through for a look at the IDEA Tempe campus.